Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Providers Satisfied with Carriers/MACs
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology
Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology
  See all
hormone-dependant tumors;agressive characteristics Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
A significant proportion of elderly patients develop hormone-dependant “luminal-B” tumours associated with aggressive characteristics
Critical Reviews in Oncology/Hematology, 07/01/08
Print     Email This Article     Save in My Library   Free Abstract
Durbecq V et al. - In a trial to investigate the influence of ageing on the incidence of breast cancer (BC) molecular subtypes, it was shown that age has a great influence on the incidence of BC molecular subtypes

Methods
  • According to their bio-characteristics, 61% of the samples could be assigned to a molecular subtype: the “HER-2+”, the “ER & HER2 negative”, or 1 of the 2 “luminal-like” subtypes divided according to their histological grade (“A” [HER-2-/ER+/grade 1–2] and “B” [HER-2-/ER+/grade 3])

Results
  • Pts <40 develop a statistically higher rate of high grade proliferating “HER-2” (27%) and “ER & HER2 negative” (31%) BC, whereas pts >50 develop mostly less aggressive hormone-dependant “luminal-A” BC (>67%)
  • A significant proportion of pts >70 develop “luminal-B” (19%) tumours associated with high proliferation, high grade, large size, and nodal invasion

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.